Navigation Links
Hologic to Present at Citi's 2009 Sixth Annual Small/Mid Cap Conference
Date:10/20/2009

BEDFORD, Mass., Oct. 20 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced that Glenn Muir, Chief Financial Officer, will present at Citi's 2009 Sixth Annual Small/Mid Cap Conference in New York City on Thursday, November 19, 2009, at 9:10 a.m. (EST).

Interested parties are invited to listen to a live audio webcast of Hologic's presentation on the investor section of the company's website at www.hologic.com/investors-overview. An archive of the presentation will be available for replay following the conference.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.

    Contact: Deborah Gordon
             Vice President, Investor Relations
             Hologic, Inc.
             (781) 999-7716

SOURCE Hologic, Inc.


'/>"/>
SOURCE Hologic, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
2. ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrigs Disease
3. Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
4. Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer
5. Clinical and Histopathological Results Using Pollogens TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy
6. Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
7. OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer
8. Hologic Expands Healthcare Investment in Asia
9. Hologic to Host Investor Reception at RSNA 2009
10. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
11. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... , , LYON, France, Nov. 19 ...tes supplying dangerous and illegal medicines, Ope...dinated by INTERPOL and the World Health Organizat...eiting Taskforce (IMPACT) to highlight the dangers...lobal initiative resulted in a series of arrests a...
(Date:11/19/2009)... , , ABBOTT PARK, Ill., Nov. 19 /PRNewswi... Abbott (NYSE: ABT ) as one of its Most Admired ...ar. The Deal honored Abbott as its Most Admired...e strategic use of acquisitions and divestitures s...ott has reshaped its business portfolio with a foc...
(Date:11/19/2009)... , , NEWPORT NEWS, Va., Nov. 19 /PRNewswir...st Imaging (BSGI/MBI) has been recognized and endo...fight against breast cancer: The Society of Breast...s. Both societies published articles supporting th... technology for the early detection of breast canc...
Breaking Medicine Technology:International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3EPIX Pharmaceuticals Inc Announces the P2Y2 Gastrointestinal Early Development Candidate Program Will Be Part of the Intellectual Property Offered F 55886 1EPIX Pharmaceuticals Inc Announces the P2Y2 Gastrointestinal Early Development Candidate Program Will Be Part of the Intellectual Property Offered F 55886 2Environmental Tectonics Corporations BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 13775 1Environmental Tectonics Corporations BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 13775 2Environmental Tectonics Corporations BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 13775 3Environmental Tectonics Corporations BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber 13775 4GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with 55880 1GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with 55880 2GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with 55880 3GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with 55880 4
(Date:11/22/2009)..., WASHINGTON, Nov. 21 /PRNewswire-USNewswire/ -...wing statement upon the United States Senate,s vot...h Care legislation: ,, "Senators Arlen Specter ... and all Pennsylvanians for casting stand-up, crit...nt Obama,s historic Affordable Health Care Reform ...
(Date:11/21/2009)... , NEW YORK, Nov. 21 Milvia Lo...ew York City, recently filed suit, in Supreme Cour...he complaint alleges that while Ms. Lopez underwen... at ST. VINCENT,S HOSPITAL , doctors used an HIV ...mplaint alleges that several hours after being dis...
(Date:11/21/2009)... NH based medical credentialin...in its industry to form a partnerhsip with Amerine... This partnership will help to transform quality ... (Vocus) November 21, 2009 -- ISG Group...nounced a new agreement with Amerinet Inc., a lead...
(Date:11/21/2009)... New Haven Dental Group merges...D.S of Branford, CT. , (P...oup, comprised of partners Dr. David Gibson, Dr. D...rrester has just merged their growing practice wit...., , ,When Dr. Pickman decided he wanted to retire...
(Date:11/20/2009)... , WASHINGTON, Nov. 20 /PRNewswire-USNewswire...ng senators to modify health care reform legislati... regarding a health insurance individual coverage ...enforceable mandate will minimize adverse selectio...rules prescribed by the bill. ,, "The individua...
Breaking Medicine News(10 mins):Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:New Haven Dental Group Expands Their Vision 2Health News:Actuaries to Senate: Strengthen Individual Mandate 2
... , , Nation,s largest network of Hispanic healt...ealth care reform in 2009 , , WASHINGTON, March 5...ove access for the underinsured, and make sure tha...nce for Hispanic Health, the nation,s leading Hisp...
... Urges LCA-Vision Stockholders to Vote the GOLD Ca...aq: LCAV ) announces that RiskMetrics Group,s IS...ion stockholders vote to retain the Company,s curr...oup,s consent solicitation. After in-person meeti...
... Dr. Steven St. Peter Named to Proteon Board of Di...l, one of the world,s largest life sciences-dedica...t it is the lead investor in a $38 million Series ...utics Board of Directors. , , Proteon recently i...
... HILLSBOROUGH, Calif., March 5 Apex Bioventures A...Apex") announced today that its board of directors...siness combination in the time frame required by i...te until a plan of liquidation is approved by the ...
...ut insights into how that happens may lead to ways... March 5 (HealthDay News) -- Temozolomide, a stand...essiveness of surviving cancer cells, making tumor...s in brain tumors called gliomas that have stem ce...
... MAYWOOD, Il. -- When Joyce Moss recently arrived...ning heart attack, it took just 42 minutes to perf...dure opened up an artery that was 100 percent bloc...ngioplasty times, Loyola will become the first hos...
Other Medicine News:Health News:Alliance President and CEO Dr. Jane L. Delgado Joins President Obama at White House to Launch Health Reform Agenda 2Health News:Leading Proxy Advisory Firm RiskMetrics Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group 2Health News:Leading Proxy Advisory Firm RiskMetrics Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group 3Health News:MPM Capital Leads Investment in Proteon Therapeutics 2Health News:Apex Bioventures Acquisition Corp. To Seek Stockholder Approval To Liquidate and Dissolve 2Health News:Brain Tumor Drug May Help Spur Cancer's Return 2Health News:Brain Tumor Drug May Help Spur Cancer's Return 3Health News:Saving heart attack patients in the middle of the night 2Health News:Saving heart attack patients in the middle of the night 3Health News:Saving heart attack patients in the middle of the night 4
AVOXimeter 1000E
RF CONDUCTR (MC)
...s examined with an ocular fundus image displayed o...ge and the perimetry result, you can grasp the cor...ates with Kowa VK2 Digital imaging system enabling... perimetry results, and ensure smooth fundus image...
SkinStation Phototherapy System
Medicine Products: